• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Publications:

» (10/13/09) Comments on FDA Draft Guidance on Postmarketing Studies and Clinical Trials (HRG Publication #1894) » (12/14/07) Presentation before the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice (HRG Publication #1830) » (7/17/07) A Policy Study of Clinical Trial Registries and Results Databases (HRG Publication #1819) » (6/7/07) Letter About Ethical Concerns with Hepatitis E Vaccine Trial in the New England Journal of Medicine (HRG Publication #1814) » (4/10/07) Letter to CIOMS regarding the draft document Special Ethical Considerations for Epidemiological Research (HRG Publication #1804) » (4/2/07) Description of efforts to redesign surfactant (SURFAXIN) study in Latin America (HRG Publication #1802) » (12/4/06) Trials of Prophylaxis to Prevent Recurrent Herpes Should not Utilize a Placebo Arm (HRG Publication #1794) » (6/1/05) Letter opposing U.S. government efforts to declare some foreign ethics approval procedures equivalent to those in the U.S. (HRG Publication #1744) » (3/25/05) US exceptionalism comes to research ethics - Comment by Peter Lurie in The Lancet (HRG Publication #1732) » (9/1/04) Letter to the FDA's Office for Science and Health Coordination urging them not to abandon the Declaration of Helsinki in ensuring protection of human subjects in certain foreign clinical studies (HRG Publication #1705) » (3/1/04) Letter to World Medical Association concerning continuing efforts to amend Declaration of Helsinki (HRG Publication #1692) » (8/28/03) Letter to the World Medical Association opposing proposed changes to Paragraph 30 of the Declaration of Helsinki (HRG Publication #1674) » (7/9/03) Statement of Peter Lurie, MD, MPH before National Academy of Sciences' Committee on Clinical Research Involving Children (HRG Publication #1668) » (4/15/03) Letter to NIH Director that continues to raise ethical concerns about the “Alzheimer’s Disease Anti-Inflammatory Prevention Trial” (ADAPT) (HRG Publication #1663) » (9/3/02) Letter to HHS Secretary Tommy Thompson that raises ethical concerns about the “Alzheimer’s Disease Anti-Inflammatory Prevention Trial” (ADAPT) (HRG Publication #1637) » (5/2/01) Letter in the Journal of the American Medical Association (JAMA) on problems with the Immune Response Corporation's HIV-1 vaccine study. (HRG Publication #1573) » (4/18/01) Comments on the Food and Drug Adminstration's proposed rule concerning the disclosure of safety and effectiveness information about unapproved, investigational products--Human Gene Therapy(HRG Publication #1567) » (4/4/01) Press Release commenting on Discovery Laboratories Inc. redesigning its study of surfactant (SURFAXIN) in Latin America. (HRG Publication #1564) » (2/22/01) Request to the Department of Health and Human Services to halt plans for unethical placebo-controlled study of drug for respiratory distress syndrome in Latin America unless it is redesigned to treat all patients (HRG Publication #1558) » (3/29/99) Letter to the World Medical Association expressing alarm at the current Draft Revised Version of the Declaration of Helsinki. (HRG Publication #1477) >> more publications...

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.